Pyxis Oncology, Inc. (PYXS): Submission of Matters to a Vote of Security Holders
Pyxis Oncology, Inc. (PYXS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001782223 0001782223 2026-06-15 2026-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15,
How this was made
The 30-second read
Why it matters
The disclosure confirms quorum, director election results (Class II) and ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
Market read
This is a routine governance filing with vote tallies; it does not introduce new financial guidance, clinical, or regulatory developments.
What to watch
Director election and auditor ratification can matter for governance risk, but this filing contains no new risk event (e.g., restatement, investigation, or auditor resignation).
Background
The company submitted SEC Form 8-K under Item 5.07 to report matters voted on at its June 15, 2026 annual stockholders meeting.
Ticker impact
Pyxis Oncology filed an 8-K reporting stockholder vote results, including election of three Class II directors and ratification of Ernst & Young for 2026.
Likely minimal immediate price impact; any reaction would be sentiment/positioning rather than new fundamentals.
The filing discloses voting tallies and auditor ratification without changes to guidance, financing, litigation, or operating performance.
Market effects
No clear read-across to biotech/oncology sector fundamentals from director/auditor vote results.
None.
None.
Counterpoint
If investors were expecting a contested board outcome or auditor change, the vote totals could reduce uncertainty; however, the article provides no indication of controversy.
Key entities
- companyPyxis Oncology, Inc.
Subject of the 8-K; reported annual meeting vote results for directors and auditor ratification.
- auditorErnst & Young LLP
Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
- directorsThomas Civik; Freda Lewis-Hall; Michael A. Metzger
Elected as Class II directors to serve until the 2029 annual meeting.
